Gyre Therapeutics, Inc. GYRE Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s current ratio?
- Gyre Therapeutics, Inc. (GYRE) reported current ratio of 4.6× in Q1 2026.
- How has Gyre Therapeutics, Inc.'s current ratio changed year-over-year?
- Gyre Therapeutics, Inc.'s current ratio increased by 28.6% year-over-year, from 3.6× to 4.6×.
- What is the long-term trend for Gyre Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s current ratio has grown at a 2.2% compound annual growth rate (CAGR), from 5× to 5.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.